Hepatic complications in sickle cell disease;Complicações hepáticas na doença falciforme

Revista Brasileira de Hematologia e Hemoterapia

Volumn 29, Issue 3, 2007, Pages 299-303

  Traina, Fabíola ^a   Saad, Sara T O ^a,b  

^a Centro de Hematologia e Hemoterapia

^b Cidade Universitária Zeferino Vaz   (Brazil)

Author keywords

Hepatopathy; Sickle cell disease

Indexed keywords

EID: 38049162418     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Johnson CS, Omata M, Tong MJ, Simmons Jr. JF, Weiner J et al. Liver involvement in sickle cell disease. Medicine. 1985;64(5):349-356.
2. Mills LR, Mwakyusa D, Milner PF. Histopathologic features of liver biopsy specimens in sickle cell disease. Arch Pathol Lab Med. 1988;112(3):290-4.
3. Charlotte F, Bachir D, Nenert M, Mavier P, Galacteros F et al. Vascular lesions of the liver in sickle cell disease. A clinicopathological study in 26 living patients. Arch Pathol Lab Med. 1995;119(1):46-52.
4. Omata M, Johnson CS, Tong M, Tatter D. Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci. 1986;31(3):247-256.
5. Banerjee S, Owen C, Chopra S. Sickle cell hepatopathy. Hepatology. 2001;33(5):1021-8.
6. Norris WE. Acute hepatic sequestration in sickle cell disease. J Natl Med Assoc. 2004;96(9):1235-9.
7. Hernandez P, Dorticos E, Espinosa E, Gonzalez X, Svarch E. Clinical features of hepatic sequestration in sickle cell anaemia. Haematologia. 1989;22(3):169-174.
8. Lee ES, Chu PC. Reverse sequestration in a case of sickle crisis. Postgrad Med J. 1996;72(850):487-8.
9. Shao SH, Orringer EP. Sickle cell intrahepatic cholestasis: approach to a difficult problem. Am J Gastroenterol. 1995;90(11):2048-50.
10. Sheehy TW, Law DE, Wade BH. Exchange transfusion for sickle cell intrahepatic cholestasis. Arch Intern Med. 1980; 140 (10):1364-66.
11. O'Callaghan A, O'Brien SG, Ninkovic M, Butcher GP, Foster CS et al. Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion. Gut. 1995;37(1):144-7.
12. Bond LR, Hatty SR, Horn ME, Dick M, Meire HB et al. Gall stones in sickle cell disease in the United Kingdom. Br Med J. 1987;295 (6592):234-6.
13. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Blacket D et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333(4):206-13.
14. Haberkern CM, Neumayr LD, Orringer EP, Earles AN, Robertson SM et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the National Preoperative Transfusion Study. Preoperative Transfusion in Sickle Cell Disease Study Group. Blood. 1997;89(5):1533-42.
15. Jawad AJ, Kurban K, el-Bakry A, al-Rabeeah A, Seraj M et al. Laparoscopic cholecystectomy for cholelithiasis during infancy and childhood: cost analysis and review of current indications. World J Surg. 1998;22(1):69-73; discussion 74.
16. Al-Salem AH, Nourallah H. Sequential endoscopic/laparoscopic management of cholelithiasis and choledocholithiasis in children who have sickle cell disease. J Pediatr Surg. 1997; 32 (10):1432-35.
17. Fertrin KY, Melo MB, Assis AM, Saad ST, Costa FF. UDP- glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia. Clin Genet. 2003;64(2):160-162.
18. Passon RG, Howard TA, Zimmerman SA, Schultz WH, Ware RE. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. J Pediatr Hematol Oncol. 2001;23(7):448-451.
19. Brownell A, Lowson S, Brozovic M. Serum ferritin concentration in sickle cell crisis. J Clin Pathol. 1986;39(3):253-5.
20. Porter JB, Huehns ER. Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism. Acta Haematol. 1987;78(2-3):198-205.
21. Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A et al. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol. 2004;126(5):736-742.
22. Kwiatkowski JL, Cohen AR. Iron chelation therapy in sickle-cell disease and other transfusion-dependent anemias. Hematol Oncol Clin North Am. 2004;18(6):1355-77.
23. Adams DM, Schultz WH, Ware RE, Kinney TR. Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients. J Pediatr Hematol Oncol. 1996;18(1):46-50.
24. Hasan MF, Marsh F, Posner G, Bellevue R, Dosik H et al. Chronic hepatitis C in patients with sickle cell disease. Am J Gastroenterol. 1996;91(6):1204-06.
25. Ocak S, Kaya H, Cetin M, Gali E, Ozturk M. Seroprevalence of hepatitis B and hepatitis C in patients with thalassemia and sickle cell anemia in a long-term follow-up. Arch Med Res. 2006;37(7):895-8.
26. Hassan M, Hasan S, Castro O, Giday S, Banks A et al. HCV in sickle cell disease. J Natl Med Assoc. 2003;95(9):864-867.
27. Chuang E. Ruchelli E, Mulberg AE. Autoimmune liver disease and sickle cell anemia in children: a report of three cases. J Pediatr Hematol Oncol. 1997;19(2):159-62.
28. Richard S, Billett HH. Liver function tests in sickle cell disease. Clin Lab Haematol. 2002;24(1):21-7.
29. Brody JI, Ryan WN, Haidar MA. Serum alkaline phosphatase isoenzymes in sickle cell anemia. JAMA. 1975;232(7):738-41.
30. Schiele F, Guilmin AM, Detienne H. Siest G. Gamma-glutamyltransferase activity in plasma: statistical distributions, individual variations, and reference intervals. Clin Chem. 1977; 23(6):1023-8.
31. Green TW, Conley CL, Berthrong M. [The liver in sickle cell anemia.]. Bull Johns Hopkins Hosp. 1953;92(2):99-127.
32. Magid D, Fishman EK, Charache S, Siegelman SS. Abdominal pain in sickle cell disease: the role of CT. Radiology. 1987; 163 (2):325-8.
33. Zakaria N, Knisely A, Portmann B, Mieli-Vergani G, Wendon J et al. Acute sickle cell hepatopathy represents a potential contra-indication for percutaneous liver biopsy. Blood. 2003;101 (1):101-3.
34. Bauer TW, Moore G, Hutchins GM. The liver in sickle cell disease. A clinicopathologic study of 70 patients. Am J Med. 1980;69(6);833-7.
35. Baichi MM, Arifuddin RM, Mantry PS, Bozorgzadeh A, Ryan C. Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis. Transplantation. 2005;80(11):1630-2.
36. Gilli SC, Boin IF, Leonardi SL, Luzo AC, Costa FF et al. Liver transplantation in a patient with S(beta)0-thalassemia. Transplantation. 2002;74(6):896-8.